Intrexon expands SVP team with three new appointments

Synthetic biology specialist Intrexon Corp (NYSE: XON) has appointed Jack Bobo as senior vice president, chief communications officer, Samuel Broder as senior vice president, head of health, and Joel Liffman as senior vice president, finance.

Mr Bobo joins from the US Department of State, where he has worked for the past 13 years, most recently as senior advisor for food policy. Mr Broder joins Intrexon from Celera, where he was executive vice president and chief medical officer. Prior to joining the company, Mr Liffmann most recently served as executive vice president of corporate development at Health Grades.

Randal Kirk, chairman and chief executive of Intrexon, said: "We are delighted to welcome Jack and Joel to the Intrexon team, and excited to have Sam back in an executive role at the company. The breadth of experience these accomplished individuals contribute across their respective areas of expertise will prove valuable as we continue to push forward into new fields and partnerships building upon our leading synthetic biology position.  With these additions, our ability to effectively communicate as a responsible global citizen with all relevant stakeholders, to expand the portfolio of gene and cell therapies we enable, and to assess strategic opportunities both internally and externally has significantly increased."